Table 1.
Prepared PVA membrane samples.
| Membranes | Type | Thickness, µm | Bulk Modification | Surface Modification | ||
|---|---|---|---|---|---|---|
| Fullerenol wt % | Chitosan wt % | Quantity of Bilayers | Type of PELs | |||
| PVAdense | dense | 40 | - | 0 | - | - |
| PVA-0 *-5 *dense | dense | 40 | - | 5 | - | - |
| PVA-0-10dense | dense | 40 | - | 10 | - | - |
| PVA-0-15dense | dense | 40 | - | 15 | - | - |
| PVA-0-20dense | dense | 40 | - | 20 | - | - |
| PVA-1-20dense | dense | 40 | 1 | 20 | - | - |
| PVA-3-20dense | dense | 40 | 3 | 20 | - | - |
| PVA-5-20dense | dense | 40 | 5 | 20 | - | - |
| PVA-0-20 | supported | 1 | - | 20 | - | - |
| PVA-5-20 | supported | 1 | 5 | 20 | - | - |
| PVA-0-20/LbL-5PSS,PAH | supported | 1 | - | 20 | 5 | PSS,PAH |
| PVA-0-20/LbL-10PSS,PAH | supported | 1 | - | 20 | 10 | PSS,PAH |
| PVA-0-20/LbL-5PSS,CS | supported | 1 | - | 20 | 5 | PSS,CS |
| PVA-0-20/LbL-10PSS,CS | supported | 1 | - | 20 | 10 | PSS,CS |
| PVA-5-20/LbL-5PSS,PAH | supported | 1 | 5 | 20 | 5 | PSS,PAH |
| PVA-5-20/LbL-10PSS,PAH | supported | 1 | 5 | 20 | 10 | PSS,PAH |
| PVA-5-20/LbL-5PSS,CS | supported | 1 | 5 | 20 | 5 | PSS,CS |
| PVA-5-20/LbL-10PSS,CS | supported | 1 | 5 | 20 | 10 | PSS,CS |
| PVA-5-20/LbL-2PSS,CS | supported | 1 | 5 | 20 | 2 | PSS,CS |
| PVA-5-20/LbL-7PSS,CS | supported | 1 | 5 | 20 | 7 | PSS,CS |
| PVA-5-20/LbL-5.5PSS,CS | supported | 1 | 5 | 20 | 5.5 | PSS,CS |
| PVA-5-20/LbL-5PAA,CS | supported | 1 | 5 | 20 | 5 | PAA,CS |
* To simplify the designation of membranes, the first number after PVA refers to the content of fullerenol wt %, the second—to the content of chitosan wt %.